However, despite of the beneficial effect, anti-VEGF-A treatment has been reported to be associated with the development of geographic atrophy (GA), the degeneration of retinal pigment epithelium (RPE) followed by the death of retinal neuronal cells. The gene discussed is VEGFA; the disease is atrophic macular degeneration.